-
Overview
Date & Location
07/25/2022 – 07/25/2023, 12:00 AM CST Online
Overview
This podcast discusses COVID and the consequences of COVID in children. It also discusses the efficacy of the vaccine in children as well as the reasons why children should be vaccinated. Dr. Barton explains MISC and cardiac abnormalities in children. Differences in dosing of approved pediatric vaccines and prospects of vaccines are discussed.
Target Audience
This educational activity is designed to meet the educational goals of physicians and other healthcare professionals specializing in infectious diseases, family and community medicine, internal medicine, emergency medicine, and all those involved with the management of patients with coronavirus.
Learning Objectives for the Episode 10
- Discuss COVID in children and the reasons why children should be vaccinated.
- Describe the efficacy of the COVID vaccine in young children.
- Explain the difference in dosing between the approved pediatric vaccines and the reasons why.
- Discuss myocarditis concerns.
Program Registration Information
Registration Fees - $0.00
Continuing Medical Education Education Credit - Accreditation and Designation Statement
¸£Àû͵ÅÄ91 ÉîÒ¹¸£Àû Science Center at San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
¸£Àû͵ÅÄ91 ÉîÒ¹¸£Àû Science Center at San Antonio designates this enduring material for a maximum of .50 AMA PRA Category 1 Creditsâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificate of Attendance
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity¸£Àû͵ÅÄ91 ÉîÒ¹¸£Àû evaluation.
Release date: 07/25/2022 Credits expire: 07/25/2023
-
Faculty
​Jan E. Patterson, MD, MS, MACP
FIDSA, FSHEA, CHCP
Professor of Medicine/Infectious Diseases and Pathology
Associate Dean for Quality & Lifelong Learning
Joe R. and Teresa Lozano Long School of Medicine
¸£Àû͵ÅÄ91 ÉîÒ¹¸£ÀûDr. Patterson is a Professor of Medicine/Infectious Diseases and Associate Dean for Quality & Lifelong Learning at The Joe R. and Teresa Lozano Long School of Medicine, ¸£Àû͵ÅÄ91 ÉîÒ¹¸£Àû. She is clinician and a healthcare epidemiologist and has served on the Infectious Diseases Society of America Board of Directors and is Past President of the Society for Healthcare Epidemiology of America. She is a longtime infectious diseases consultant to Southwest Texas Regional Advisory Council (STRAC) and has also served on CDC¸£Àû͵ÅÄ91 ÉîÒ¹¸£Àû Healthcare Infection Practices Advisory Committee and has been a consultant to San Antonio Metro Health Department. She has been a site principal investigator for new antimicrobial agents and is currently a co-investigator for the NIH Adaptive COVID-19 Treatment Trial (ACTT) studies as outlined above and is a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at ¸£Àû͵ÅÄ91 ÉîÒ¹¸£Àû and University Hospital.
​Teresa Barton, MD
Associate Professor
Department of Pediatrics, Division of Pediatric Immunology & Infectious Diseases
Joe R. and Teresa Lozano Long School of Medicine
¸£Àû͵ÅÄ91 ÉîÒ¹¸£ÀûDr. Tess Barton is Associate Professor of Pediatric Infectious Diseases at the Joe R. and Teresa Lozano Long School of Medicine, ¸£Àû͵ÅÄ91 ÉîÒ¹¸£Àû, and Medical Director of the Pediatric Infectious Disease Program at University Health. She is a clinician/educator, with particular interest in HIV, adolescent sexually transmitted infections, tropical diseases and global health. She is new to San Antonio, joining the university after serving as the Chief Medical Officer for the Baylor Pediatric AIDS Initiative, and doing extensive global health work in Asia and Africa. Her COVID work began when she was working in New York City at the beginning of the pandemic and has continued here. She serves as a pediatric representative on several COVID planning groups with UT/University Health, and local school districts.
Relevant Financial Disclosures
Dr. Jan Patterson has been a site principal investigator for new antimicrobial agents and was a co-investigator for the NIH Adaptive COVID-19 Treatment Trial (ACTT) studies, NIH Accelerating COVID-10 Therapeutic Interventions and Vaccines studies (ACTIV-6) and a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at ¸£Àû͵ÅÄ91 ÉîÒ¹¸£Àû and University Hospital.
Dr. Theresa Barton has nothing to disclose.
